JP2022514385A5 - - Google Patents
Info
- Publication number
- JP2022514385A5 JP2022514385A5 JP2021535679A JP2021535679A JP2022514385A5 JP 2022514385 A5 JP2022514385 A5 JP 2022514385A5 JP 2021535679 A JP2021535679 A JP 2021535679A JP 2021535679 A JP2021535679 A JP 2021535679A JP 2022514385 A5 JP2022514385 A5 JP 2022514385A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- hydrogen
- independently
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024094279A JP7858720B2 (ja) | 2018-12-21 | 2024-06-11 | 3α-ヒドロキシ-17β-アミド神経刺激性ステロイドおよびその組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862784229P | 2018-12-21 | 2018-12-21 | |
| US201862784222P | 2018-12-21 | 2018-12-21 | |
| US62/784,229 | 2018-12-21 | ||
| US62/784,222 | 2018-12-21 | ||
| PCT/US2019/067953 WO2020132504A1 (en) | 2018-12-21 | 2019-12-20 | 3.alpha.-hydroxy-17.beta.-amide neuroactive steroids and compositions thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094279A Division JP7858720B2 (ja) | 2018-12-21 | 2024-06-11 | 3α-ヒドロキシ-17β-アミド神経刺激性ステロイドおよびその組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514385A JP2022514385A (ja) | 2022-02-10 |
| JP2022514385A5 true JP2022514385A5 (cg-RX-API-DMAC7.html) | 2022-11-18 |
| JP7692830B2 JP7692830B2 (ja) | 2025-06-16 |
Family
ID=69591712
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535679A Active JP7692830B2 (ja) | 2018-12-21 | 2019-12-20 | 3α-ヒドロキシ-17β-アミド神経刺激性ステロイドおよびその組成物 |
| JP2024094279A Active JP7858720B2 (ja) | 2018-12-21 | 2024-06-11 | 3α-ヒドロキシ-17β-アミド神経刺激性ステロイドおよびその組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094279A Active JP7858720B2 (ja) | 2018-12-21 | 2024-06-11 | 3α-ヒドロキシ-17β-アミド神経刺激性ステロイドおよびその組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220372067A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3898646B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7692830B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210107050A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113195512A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019403415B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021012242A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3124371A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL284183A (cg-RX-API-DMAC7.html) |
| MX (2) | MX2021007504A (cg-RX-API-DMAC7.html) |
| TW (2) | TWI848034B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020132504A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201606063RA (en) | 2012-01-23 | 2016-09-29 | Sage Therapeutics Inc | Neuroactive steroid formulations and methods of treating cns disorders |
| RS62761B1 (sr) | 2012-08-21 | 2022-01-31 | Sage Therapeutics Inc | Alopregnanolon za lečenje refraktornog epileptičkog statusa |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| IL312610B2 (en) | 2018-12-05 | 2026-05-01 | Sage Therapeutics Llc | Neuroactive steroids and methods of using them |
| TWI848034B (zh) * | 2018-12-21 | 2024-07-11 | 美商賽吉醫療公司 | 神經活性類固醇及其組合物 |
| CN115768781A (zh) * | 2020-06-24 | 2023-03-07 | 萨奇治疗股份有限公司 | 3.α.-羟基,17.β.-C(O)-N-芳基取代的神经活性类固醇及其组合物 |
| CN119192275B (zh) * | 2024-08-22 | 2025-05-30 | 湖南玉新药业有限公司 | 一种3-羰基-4-氮杂-5α-雄甾-17β-羧酸化合物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| EP4717314A2 (en) | 2011-10-14 | 2026-04-01 | Sage Therapeutics, LLC | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| US9512170B2 (en) * | 2013-03-01 | 2016-12-06 | Washington University | Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors |
| MY190408A (en) * | 2014-10-16 | 2022-04-21 | Sage Therapeutics Inc | Compositions and methods for treating cns disorders |
| DK3258939T3 (da) * | 2015-02-20 | 2022-12-12 | Sage Therapeutics Inc | Neuroaktive steroider, sammensætninger og anvendelser heraf |
| WO2018013613A1 (en) * | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| IL312610B2 (en) * | 2018-12-05 | 2026-05-01 | Sage Therapeutics Llc | Neuroactive steroids and methods of using them |
| TWI848034B (zh) * | 2018-12-21 | 2024-07-11 | 美商賽吉醫療公司 | 神經活性類固醇及其組合物 |
-
2019
- 2019-12-20 TW TW108147086A patent/TWI848034B/zh active
- 2019-12-20 TW TW113121961A patent/TWI892697B/zh active
- 2019-12-20 BR BR112021012242-7A patent/BR112021012242A2/pt unknown
- 2019-12-20 MX MX2021007504A patent/MX2021007504A/es unknown
- 2019-12-20 CA CA3124371A patent/CA3124371A1/en active Pending
- 2019-12-20 KR KR1020217022533A patent/KR20210107050A/ko not_active Ceased
- 2019-12-20 EP EP19850836.8A patent/EP3898646B1/en active Active
- 2019-12-20 WO PCT/US2019/067953 patent/WO2020132504A1/en not_active Ceased
- 2019-12-20 AU AU2019403415A patent/AU2019403415B2/en active Active
- 2019-12-20 CN CN201980085054.3A patent/CN113195512A/zh active Pending
- 2019-12-20 JP JP2021535679A patent/JP7692830B2/ja active Active
- 2019-12-20 US US17/416,367 patent/US20220372067A1/en active Pending
-
2021
- 2021-06-18 MX MX2025000126A patent/MX2025000126A/es unknown
- 2021-06-20 IL IL284183A patent/IL284183A/en unknown
-
2024
- 2024-06-11 JP JP2024094279A patent/JP7858720B2/ja active Active
-
2025
- 2025-11-13 AU AU2025267433A patent/AU2025267433A1/en not_active Abandoned